Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2011 1
2014 2
2015 1
2016 2
2017 4
2018 1
2019 1
2021 1
2022 8
2023 2
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis.
Gisondi P, Altomare G, Ayala F, Bardazzi F, Bianchi L, Chiricozzi A, Costanzo A, Conti A, Dapavo P, De Simone C, Foti C, Naldi L, Offidani A, Parodi A, Piaserico S, Prignano F, Rongioletti F, Stingeni L, Talamonti M, Girolomoni G. Gisondi P, et al. J Eur Acad Dermatol Venereol. 2017 May;31(5):774-790. doi: 10.1111/jdv.14114. Epub 2017 Feb 27. J Eur Acad Dermatol Venereol. 2017. PMID: 28244153
A total of 20 dermatologists from different areas of Italy and with large experience in the treatment of psoriasis agreed to participate in the guidelines expert panel who aimed to reach consensus on the factors influencing psoriasis severity, the indications …
A total of 20 dermatologists from different areas of Italy and with large experience in the treatment of psoriasis agreed to particip …
Update on the Management of Pediatric Psoriasis: An Italian Consensus.
Peris K, Fortina AB, Bianchi L, Fabbrocini G, Gisondi P, Balato A, Bardazzi F, Bernardini N, Bonamonte D, Bongiorno MR, Buligan C, Cusano F, Del Giudice MBF, El Hachem M, Fargnoli MC, Gualdi G, Guarneri C, Hansel K, Malara G, Mazzatenta C, Micali G, Narcisi A, Neri I, Oranges T, Panzone M, Parodi A, Restano L, Simonetti O, Venturini M, Di Lernia V. Peris K, et al. Dermatol Ther (Heidelb). 2022 Aug;12(8):1753-1775. doi: 10.1007/s13555-022-00758-2. Epub 2022 Jul 1. Dermatol Ther (Heidelb). 2022. PMID: 35776408 Free PMC article.
INTRODUCTION: Psoriasis affects children with a considerable burden in early life. Treating pediatric psoriasis is challenging also because of the lack of updated specific guidelines. ...METHODS: In September 2021, a board of six Italian dermatologists …
INTRODUCTION: Psoriasis affects children with a considerable burden in early life. Treating pediatric psoriasis is challenging …
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).
Orsini D, Megna M, Assorgi C, Balato A, Balestri R, Bernardini N, Bettacchi A, Bianchelli T, Bianchi L, Buggiani G, Burlando M, Brunasso A, Caldarola G, Cameli N, Campanati A, Campione E, Carugno A, Chersi K, Conti A, Costanzo A, Cozzani E, Cuccia A, D'Amico D, Dal Bello G, Dall'Olio EG, Dapavo P, De Simone C, Di Brizzi EV, Di Cesare A, Dini V, Esposito M, Errichetti E, Fargnoli MC, Fiorella CS, Foti A, Fratton Z, Gaiani FM, Gisondi P, Giuffrida R, Giunta A, Guarneri C, Legori A, Loconsole F, Malagoli P, Narcisi A, Paolinelli M, Potestio L, Prignano F, Rech G, Rossi A, Skroza N, Trovato F, Venturini M, Richetta AG, Pellacani G, Dattola A. Orsini D, et al. J Dermatolog Treat. 2024 Dec;35(1):2393376. doi: 10.1080/09546634.2024.2393376. Epub 2024 Aug 20. J Dermatolog Treat. 2024. PMID: 39164008 Free article.
Patients aged 65 years, with moderate-to-severe plaque psoriasis and treated with bimekizumab were enrolled. No exclusion criteria were applied. Bimekizumab was administered following the Italian Guidelines for the management of plaque psoriasis and ac …
Patients aged 65 years, with moderate-to-severe plaque psoriasis and treated with bimekizumab were enrolled. No exclusion criteria we …
Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA).
Argenziano G, Cusano F, Corazza M, Amato S, Amerio P, Naldi L, Patruno C, Pigatto PD, Quaglino P, Gisondi P, Chiricozzi A, Tonon F, Stingeni L, Calzavara-Pinton P, Wollenberg A, Kinberger M, Arents BW, Aszodi N, Avila Valle GL, Barbarot S, Bieber T, Brough HA, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens LA, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. Argenziano G, et al. Ital J Dermatol Venerol. 2024 Jun;159(3):223-250. doi: 10.23736/S2784-8671.24.07664-3. Epub 2024 May 10. Ital J Dermatol Venerol. 2024. PMID: 38727633 Free article.
SIDeMaST (Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e delle Malattie Sessualmente Trasmesse) contributed to the development of the present guideline on the systemic treatment of chronic plaque psoriasis. With the permission of EuroGuiDerm, SIDeMaST adap …
SIDeMaST (Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e delle Malattie Sessualmente Trasmesse) contributed to the developm …
Pustular psoriasis with a focus on generalized pustular psoriasis: classification and diagnostic criteria. An Italian expert consensus.
Costanzo A, Bardazzi F, DE Simone C, Fabbrocini G, Foti C, Marzano AV, Naldi L, Parodi A, Prignano F, Girolomoni G. Costanzo A, et al. Ital J Dermatol Venerol. 2022 Dec;157(6):489-496. doi: 10.23736/S2784-8671.22.07415-1. Ital J Dermatol Venerol. 2022. PMID: 36651202 Free article. Review.
Generalized pustular psoriasis (GPP) is a severe and life-threatening systemic disease associated with significant morbidity and mortality. Recent progress has been made in understanding the pathogenetic pathways involved in GPP and an intricate interaction between innate …
Generalized pustular psoriasis (GPP) is a severe and life-threatening systemic disease associated with significant morbidity and mort …
Treatment of severe psoriasis in children: recommendations of an Italian expert group.
Fortina AB, Bardazzi F, Berti S, Carnevale C, Di Lernia V, El Hachem M, Neri I, Gelmetti CM, Lora V, Mazzatenta C, Milioto M, Moretta G, Patrizi A, Peris K, Villani A. Fortina AB, et al. Eur J Pediatr. 2017 Oct;176(10):1339-1354. doi: 10.1007/s00431-017-2985-x. Epub 2017 Aug 23. Eur J Pediatr. 2017. PMID: 28836064
No conventional systemic treatments are approved for pediatric psoriasis. Adalimumab is approved by the European Medicines Agency as a first-line treatment for severe chronic plaque psoriasis in children ( 4 years old) and adolescents. ...These treatment recommendat …
No conventional systemic treatments are approved for pediatric psoriasis. Adalimumab is approved by the European Medicines Agency as …
Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines.
Altomare G, Ayala F, Bardazzi F, Bellia G, Chimenti S, Colombo D, Flori ML, Girolomoni G, Micali G, Parodi A, Peris K, Vena GA. Altomare G, et al. G Ital Dermatol Venereol. 2016 Aug;151(4):432-5. Epub 2015 Mar 19. G Ital Dermatol Venereol. 2016. PMID: 25786483
Cyclosporine (CsA) is an effective and safe therapeutic option in various dermatoses in both adults and children. Over the last 25 years, Italian dermatologists have gained relevant experience about the use of CsA in the treatment of psoriasis and atopic dermatitis, …
Cyclosporine (CsA) is an effective and safe therapeutic option in various dermatoses in both adults and children. Over the last 25 years, …
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis).
Gargiulo L, Ibba L, Malagoli P, Amoruso F, Argenziano G, Balato A, Bardazzi F, Burlando M, Carrera CG, Damiani G, Dapavo P, Dini V, Fabbrocini G, Franchi C, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Megna M, Sampogna F, Travaglini M, Costanzo A, Narcisi A. Gargiulo L, et al. Front Med (Lausanne). 2023 Jul 3;10:1196966. doi: 10.3389/fmed.2023.1196966. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37469659 Free PMC article.
It has been approved for the treatment of moderate-to-severe plaque psoriasis after being evaluated in three Phase-3 trials. However, long-term data on brodalumab in a real-life setting are still limited. METHODS: The aim of this study was to evaluate the long-term effecti …
It has been approved for the treatment of moderate-to-severe plaque psoriasis after being evaluated in three Phase-3 trials. However, …
A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis-IL PSO (Italian Landscape Psoriasis).
Valenti M, Ibba L, Cascio Ingurgio R, Malagoli P, Carugno A, Campoli M, Carrera CG, Gaiani FM, Strippoli D, Mola F, Marzano AV, Zerbinati N, Minuti A, Costanzo A, Narcisi A. Valenti M, et al. Dermatol Ther (Heidelb). 2024 Nov;14(11):2987-2997. doi: 10.1007/s13555-024-01270-5. Epub 2024 Oct 13. Dermatol Ther (Heidelb). 2024. PMID: 39397217 Free PMC article.
INTRODUCTION: Guselkumab, a human monoclonal antibody targeting the p19 subunit of interleukin-23 (IL-23), has shown efficacy in psoriasis and psoriatic arthritis. However, long-term real-world data on its effectiveness in patients with inadequate response to ustekinumab a …
INTRODUCTION: Guselkumab, a human monoclonal antibody targeting the p19 subunit of interleukin-23 (IL-23), has shown efficacy in psoriasi …
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas.
Michelucci A, Margiotta FM, Cartocci A, Panduri S, Trovato E, Calpalbo E, Dragotto M, Di Cesare A, Rosi E, Rossari S, Magnano M, Pescitelli L, Buggiani G, Simoni B, Lorenzoni E, Ricceri F, Savarese I, Milanesi N, Rubegni P, Prignano F, Romanelli M. Michelucci A, et al. Arch Dermatol Res. 2024 May 25;316(6):272. doi: 10.1007/s00403-024-03146-2. Arch Dermatol Res. 2024. PMID: 38796581
Psoriasis, a chronic inflammatory condition, often presents challenges in treatment, particularly in areas such as nails, palms/soles, scalp/face, and genitalia. ...This multicenter retrospective study aimed to evaluate the drug survival at 12 and 36 months of 191 psori …
Psoriasis, a chronic inflammatory condition, often presents challenges in treatment, particularly in areas such as nails, palms/soles …
27 results